The approach for the Plastid Company is to produce great quantities of plastids or mini cells in the plants. There are millions of these cells in each plant and they will function as efficient bio factories. The proteins will be used by research laboratories, the health service, the feed and fish industries and the pharmaceutical industry.
In addition to standard proteins Plastid will also design and produce new proteins and enzymes in demand by the market.
The production of proteins in plastids has until now been difficult, partly because it is a complicated process to put a gene into a plastid and then make a plant grow from this single plant cell.
By applying our procedures we get the right plant after two to three months. The aim is to shorten the process to one to two months. When we have the plant which produces the protein demanded by the customer, we can simply expand – we will just grow more plants. Møller says.
The Plastid Company can develop products adapted to all illnesses caused by defective proteins. A particularly interesting area is the so-called kinases, proteins which are active in transmission of signals in our body. Defect kinases cause around 400 different serious illnesses from cancer to neurological ailments.
One example is stomach cancer where a special kinase is always switched on. Stomach cancer patients therefore need inhibitors of this kinase. They must be developed continuously since our patients become resistant to inhibitors after a while, Møller explains.
We want to produce kinases in our system which may be used for developing new inhibitors for these patients. We have already managed to produce a kinase, even though this is a process in which success is not easily achieved. It shows that we are able to manage this within our patented system. There is a large market for new proteins in the industry, but the infrastructure has so far been expensive. Plastid's system is robust and the production can easily be increased or reduced, Møller says.
Silje Stangeland | alfa
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Life Sciences
20.04.2018 | Life Sciences
19.04.2018 | Materials Sciences